LifeStance Health Group, Inc. reported $1.58B of revenue over the trailing twelve months, +20% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.58B (to Q2 2026). Net income: $51M, trailing twelve months to Q2 2026. Free cash flow: $174M, trailing twelve months to Q2 2026. Operating margin: 4.8%, trailing twelve months to Q2 2026.

LFSTLifeStance Health Group, Inc.

Healthcare

$12.43+138% 1Y

$12.43

$4.8152 weeks$13.39

LFST as reported

LifeStance Health Group, Inc. reported $1.58B of revenue over the trailing twelve months, +20% on the year before. 9 reported series are charted on this page, each one as filed.

$1.58B

Revenue, trailing twelve months · to Q2 2026 · +20% against the twelve months before

Net income: $51M
Net income · −633% year on year · trailing twelve months to Q2 2026
Free cash flow: $174M
Free cash flow · +45% year on year · trailing twelve months to Q2 2026
Operating margin: 4.8%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for LFST, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.58B	+20%	Q2 2026
Net income	$51M	−633%	Q2 2026
EPS	$0.13	−360%	Q2 2026
Operating margin	4.8%	n/a	Q2 2026
Net margin	3.1%	n/a	Q2 2026
ROE	1.3%	n/a	Q2 2026
ROA	0.85%	n/a	Q2 2026
ROIC	2.0%	n/a	Q2 2026
Free cash flow	$174M	+45%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.